| Research ID |
Investigator Name |
Research Topic |
Research Status |
EC Status |
| 1 | Panu | Disease Progression of Type 2 Diabetes Mellitus: A cohort profile | For graduation | Yes
|
| 2 | Panu | Retinopathy prediction in type 2 diabetes: time-varying Cox proportional hazards and machine learning models | Published | Yes
|
| 3 | Teerapat | Treatment effectiveness of second-line drugs in prevention of HF | For graduation | Yes
|
| 4 | Teerapat | Prognostic factors of HF in T2D | MS submitted | Yes
|
| 5 | Sukanya | Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes | Published | Yes
|
| 6 | Thitiya | Effect of second-line drugs on diabetic ratinopathy | MS submitted | Yes
|
| 7 | Thunyarat | Effect of second-line drugs on fatty liver (NAFLD/NASH) | On going | Yes
|
| 8 | Nathorn | GLP1 and BMI | On going | Yes
|
| 9 | Montarat | Cost-Utility Analysis of Laparoscopic Bariatric Surgery for Obesity with type II Diabetes Mellitus | Published | Yes
|
| 12 | Thunyarat | Short and Long term outcomes between patients who are treated in DM clinic vs non-DM clinic | On going | Yes
|
| 13 | Ammarin | Association of statin therapy initiation with diabetes progression (TE+mediation) | Approved | No
|
| 14 | Ammarin | T2D real-world medications use | Drafting MS | No
|
| 15 | Thitiya | Cucurmin supplement and glycemic control | On going | Yes
|
| 30 | Oraluck | Cost-Effectiveness of Second-line Drugs for Improved Glycaemic Control for Type 2 Diabetes Mellitus in Thailand | Drafting MS | Yes
|
| 31 | Sukanya | Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: A difference in difference analysis | Published | Yes
|
| 32 | Rou Teh | Ability of Visit-to-Visit Glucose Variability on Diabetes Complications | MS submitted | Yes
|
| 35 | Ammarin | Effects of curcumin supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: an umbrella review and updated meta-analysis | Published | Yes
|
| 36 | Amarit | Effects of second-line antihyperglycemic medications on chronic kidney disease progression: A multistate analysis | Published | Yes
|
| 43 | Panu | Treatment effectiveness of VEGF and laser on ocular and systemic outcomes in diabetic retinopathy | For graduation | Yes
|
| 44 | Hataikarn | Effect of second-line drugs on osteoporosis and/or fractures | On going | Yes
|
| 45 | Sukanya | Clinical effect of SGLT2i on CKD, CVD; Mediation analysis | On going | Yes
|
| 46 | Amarit | Individual treatment effects of sodium-glucose cotransporter-2 inhibitors on the risk of chronic kidney disease using ML | MS submitted | Yes
|
| 47 | Tanawan | Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective cohort study | Published | Yes
|
| 48 | Sukanya | Individual treatment effects of sodium-glucose cotransporter-2 inhibitors on the risk of chronic kidney disease in patients with type 2 diabetes: A counterfactual prediction model based on real-world data | Published | Yes
|
| 49 | Romen | Multiple Imputation by Chained Equations using Conventional and Machine Learning Models accounting for Uncertainty | On going | No
|
| 52 | Sukanya | Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial | Published | Yes
|
| 53 | Panu | A multistate models of T2D progression: Conventional statistical and machine learning models | Available topic | No
|
| 58 | Thunyarat | Effect of second-line drugs on metabolic dysfunction-associated fatty liver disease (MAFLD) | On going | Yes
|
| 64 | Amarit | SGLT2i effect on AKI patients: A multistate analysis from multicenter data | On going | No
|
| 66 | Amarit | Monotherapy va combined anti-diabetic drugs in T2D | On going | Yes
|
| 157 | Prapimporn | Weight regained and factors associated in GLP1-RA usage in T2DM patients: A real-world study | On going | No
|
| 158 | Amarit | Conditional average treatment effect of sodium-glucose cotransporter-2 inhibitor in lowering chronic kidney disease risk: A double/debiased machine learning approach | Analysis | No
|
| 159 | Surakiat | Predictors of Heart Failure for Thai Diabetic Patients without Established Atherosclerotic Cardiovascular Disease (ASCVD) | For graduation | Yes
|
| 160 | Sukanya | Counterfactual prognostic model under hypothetical treatment of SGLT2i in type 2 diabetes: CVD Outcome | Analysis | Yes
|
| 161 | Montarat | T2D-Bariatric surgery-continued | Analysis | No
|
| 162 | Thitiya | Treatment effectiveness of SGLT2 on kidney stone | Under review | Yes
|
| 169 | Ammarin | Adherence to Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes | Approve topic | No
|
| 177 | Atittaya | Incidence of Diabetes remission and association with microvascular and macrovascular complications in patient with newly diagnosed of type 2 Diabetes mellitus in Ramathibodi hospital: A Retrospective cohort study | Analysis | Yes
|
| 178 | Gasit | Clinical outcomes between stopping and continuing of metformin in patients with type 2 diabetes and advanced chronic kidney disease, retrospective cohort and target trial emulation study | On going | Yes
|
| 185 | Tanawan | Risk factors and disease progression of non-alcoholic fatty liver disease in adult patients with type 2 diabetes. | On going | No
|